Foxa1 is essential for mammary duct formation

Area of Science:

• * Molecular biology
• * Cancer research
• * Developmental biology

Background:

• * Forkhead box protein A1 (FOXA1) is vital for human breast cancer cell proliferation, especially in ERα-positive subtypes.
• * Previous genetic studies on Foxa1's role in mammary tumor formation were limited by the absence of conditional gene ablation models.
• * Understanding Foxa1's function in mammary gland development and tumorigenesis requires effective in vivo models.

Purpose of the Study:

• * To evaluate three distinct mouse models for mammary-specific ablation of the Foxa1 gene.
• * To identify the optimal model for achieving complete and mammary-specific deletion of Foxa1.
• * To establish a reliable system for future in vivo functional studies of Foxa1 in mammary gland development and cancer.

Main Methods:

• * Mammary-specific ablation of Foxa1 in Foxa1(loxP/loxP) mice using three different Cre-driver lines: MMTV-Cre, MMTV-rtTA;Tet-On-Cre, and Krt14-Cre.
• * Assessment of mammary duct formation and Foxa1 deletion efficiency in each model.
• * Proposed inducible ablation model using Krt14-rtTA;Tet-On-Cre.

Main Results:

• * MMTV-Cre and MMTV-rtTA;Tet-On-Cre models resulted in partial Foxa1 deletion and attenuated mammary duct formation.
• * Krt14-Cre mediated complete ablation of Foxa1 in Foxa1(loxP/loxP) mice, leading to abolished mammary duct formation.
• * Foxa1 is demonstrated to be essential for normal mammary duct development.

Conclusions:

• * Complete ablation of Foxa1 is essential for mammary duct formation.
• * The Krt14-Cre model provides a robust system for complete mammary-specific Foxa1 ablation.
• * An inducible Krt14-driven system (Krt14-rtTA;Tet-On-Cre) offers a powerful tool for future in vivo research on Foxa1's role in mammary gland biology and cancer.